Mrs. Magdalena Kovac, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 24 Cecil St Ne, Navarre, OH 44662 Phone: 330-879-2243 Fax: 330-879-2243 |
News Archive
Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.
The nanoparticle targets only leukemic cells and therefore would reduce the severe adverse effects of current treatments.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).
Proteins are large molecular chains that move around cells carrying vital information on the activity of the organism. The role of each protein depends largely on the form it takes, but the proteins occasionally lose this form when they collide and bind with other proteins.
Pregnant black women who participate in a few sessions of behavioral counseling are more likely to reduce certain risky behaviors than those who participate in standard prenatal care, according to a study published in the September issue of the journal Obstetrics & Gynecology, Reuters Health reports.
› Verified 4 days ago